Get Allergic Bronchopulmonary Aspergillosis Treatment Online

ABPA is a hypersensitivity lung condition caused by an abnormal immune reaction to Aspergillus fumigatus, a common mold that colonizes the airways of susceptible individuals. It occurs most often in people with asthma or cystic fibrosis and can lead to repeated episodes of inflammation, mucus plugging, and, over time, permanent airway damage called bronchiectasis.

The most common symptoms include wheezing, chronic cough, coughing up brownish or reddish-brown mucus plugs, shortness of breath, low-grade fever during flares, and fatigue. Some patients also experience chest tightness or recurrent episodes that look like worsening asthma attacks unresponsive to standard inhalers.

Diagnosis typically involves a combination of clinical history, elevated total serum IgE (usually above 1,000 IU/mL), positive Aspergillus-specific IgE or skin-prick testing, characteristic findings on chest imaging such as central bronchiectasis or mucus plugging, and sometimes elevated blood eosinophils. A physician will review your history and available test results to establish the diagnosis.

The main treatments are oral corticosteroids such as prednisone, which reduce acute inflammation, and oral antifungals such as itraconazole, which lower the Aspergillus load in the airways and help prevent relapses. Inhaled corticosteroid and bronchodilator combinations are used to manage the asthma component. In selected patients with high IgE and poorly controlled disease, the anti-IgE biologic omalizumab may be considered.

ABPA cannot be permanently cured, but it can be brought into remission with appropriate treatment. Many patients go years between flares with proper monitoring of IgE levels, lung function, and symptom control. Some patients do experience recurrent exacerbations and require longer-term or repeated courses of therapy.

An acute flare is typically treated with oral prednisone over several months, with the dose gradually tapered based on symptom improvement and IgE response. Itraconazole is often continued for four to six months or longer. Long-term follow-up with periodic IgE measurements is important to detect early relapse and guide treatment decisions.

Doctronic uses an AI-driven evaluation to gather a detailed picture of your symptoms, medical history, and current medications. A licensed physician then reviews your case, confirms appropriateness for online treatment, and provides a personalized treatment plan. All consultations are doctor-reviewed and HIPAA-compliant.

Yes. Doctronic connects you with real, licensed physicians who are trained to evaluate and manage complex conditions like ABPA. Every treatment plan is reviewed and audited by a qualified clinician. Our platform is HIPAA-compliant and designed to ensure your safety and privacy throughout the process.